These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28237320)

  • 1. A perspective on metabolic surgery from a gastroenterologist.
    Syu YF; Inui A; Chen CY
    J Pharmacol Sci; 2017 Feb; 133(2):61-64. PubMed ID: 28237320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
    Jirapinyo P; Haas AV; Thompson CC
    Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.
    Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M
    J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
    de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
    Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.
    Castagneto Gissey L; Casella Mariolo J; Mingrone G
    Peptides; 2018 Feb; 100():114-122. PubMed ID: 29412812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
    Malin SK; Kashyap SR
    Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity.
    Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Bariatric Surgery on Energy Homeostasis.
    Li W; Richard D
    Can J Diabetes; 2017 Aug; 41(4):426-431. PubMed ID: 28739098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
    Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
    Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative metabolic operations.
    Cohen R; Caravatto PP; Petry TZ
    Surg Obes Relat Dis; 2016 Jul; 12(6):1247-55. PubMed ID: 27317607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis.
    Patel RT; Shukla AP; Ahn SM; Moreira M; Rubino F
    Obesity (Silver Spring); 2014 Jan; 22(1):159-69. PubMed ID: 23512969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
    Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
    Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatments for obesity.
    Vetter ML; Dumon KR; Williams NN
    Psychiatr Clin North Am; 2011 Dec; 34(4):881-93. PubMed ID: 22098811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric surgery in managing diabetes mellitus.
    Roslin MS; Cripps CN
    Curr Opin Gastroenterol; 2016 Nov; 32(6):481-486. PubMed ID: 27607341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliopancreatic limb plays an important role in metabolic improvement after duodenal-jejunal bypass in a rat model of diabetes.
    Miyachi T; Nagao M; Shibata C; Kitahara Y; Tanaka N; Watanabe K; Tsuchiya T; Motoi F; Naitoh T; Unno M
    Surgery; 2016 May; 159(5):1360-71. PubMed ID: 26767308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical therapy for diabesity.
    Arroyo K; Kini SU; Harvey JE; Herron DM
    Mt Sinai J Med; 2010; 77(5):418-30. PubMed ID: 20960546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
    Escalona A; Pimentel F; Sharp A; Becerra P; Slako M; Turiel D; Muñoz R; Bambs C; Guzmán S; Ibáñez L; Gersin K
    Ann Surg; 2012 Jun; 255(6):1080-5. PubMed ID: 22534421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measures of glucose homeostasis during and after duodenal exclusion using a duodenal-jejunal bypass liner in a normoglycemic, nonobese canine model.
    Paszkiewicz RL; Burch MA; Asare Bediako I; Mkrtchyan H; Piccinini F; Ader M; Bresee C; Bergman RN
    Surg Obes Relat Dis; 2022 Jun; 18(6):694-702. PubMed ID: 35361540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.